Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased risk of hematologic SPMs, according to a review published online April 6 in Frontiers in Oncology.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗